To: Ohioan from Florida; Aquinasfan; NYer
The problem with adult stem cells is that the treatment must be customized for the patent. The issue never was which (adult of fetal) were the best choice for the patient.
Clearly adult stem cells from the patient circumvent the problem of rejection and that alone makes it a better choice. However, it does not lend it's self to mass production by the drug companies, and therefore is less profitable.
Fetal cells (even though anti rejection drugs would be required for the life of the patient), are more suited to the mass production of pharmaceuticals.
Follow the money...
20 posted on
12/07/2004 9:22:01 AM PST by
babygene
(Viable after 87 trimesters)
To: babygene
Clearly adult stem cells from the patient circumvent the problem of rejection and that alone makes it a better choice. However, it does not lend it's self to mass production by the drug companies, and therefore is less profitable. That makes sense.
I heard the author of "Overdosing America" on CSPAN this weekend. Veeeeeeery interesting.
22 posted on
12/07/2004 11:23:02 AM PST by
Aquinasfan
(Isaiah 22:22, Rev 3:7, Mat 16:19)
To: babygene
"are more suited to the mass production of pharmaceuticals.
Follow the money..."
To be fair, mass production of stem cell treatment would make treatment more affordable as well. Customized adult stem cell treatment will always be more expensive than a one treatment fits all approach.
24 posted on
12/07/2004 12:16:26 PM PST by
monday
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson